U.S. Sen. Mike Braun (R-Ind.), whom 340B covered entities have considered both a friend and foe, has decided to run for governor of Indiana in 2024 rather than seek reelection to the Senate.
A senator since 2019, Braun serves on the Health, Education, Labor, and Pensions Committee which has jurisdiction over the 340B program. Drug manufacturer Eli Lilly is one of Indiana’s main employers. The state’s health systems are another.
U.S. Sen. Mike Braun (R-Ind.), whom 340B covered entities have considered both a friend and foe, has decided to run for governor of Indiana in 2024 rather than seek reelection to the Senate.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
